Getting to the root of problem
Pfizer is a therapy leader in Inflammation & Immunology. Many chronic inflammatory diseases are poorly managed by existing treatments that provide Suboptimal relief1. Our goal is to transform the treatment landscape by addressing the root cause of inflammation at the molecular level through advanced approaches that target inflammation of the joints and skin by disrupting pathways believed to play a role in inflammation2.
We have consistently developed and delivered medicines to help address patients’ needs in rheumatology and medical dermatology. We facilitate patient awareness and education via our Facebook page All About Arthritis and our youtube channel Psorted .
We also regularly conduct disease awareness programs for patients, as well as scientific initiatives and partnerships for healthcare professionals including national and international forums (such as INPSIRE), that bring top global experts to discuss latest scientific updates and deliberate on their experiences.
1. Bykerk V. Unmet needs in rheumatoid arthritis. J Rheumatol Suppl. 2009 Jun;82:42-6.
2. Demoruelle MK, Deane KD, Holers VM. When and where does inflammation begin in rheumatoid arthritis?. Curr Opin Rheumatol. 2014;26(1):64-71.
3. Ogdie A, de Vlam K, McInnes IB, et al Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis. RMD Open 2020;6:e001042. doi: 10.1136/rmdopen-2019-001042
Areas of Focus
Revolutionary medicines enable us to enrich and extend life for people suffering from all types of diseases.